In this episode, I talked with Sophie, a leader at the Italian pharmaceutical company Bracco, about her experiences and learnings at the Harvard’s negotiation course. Sophie shares her experiences attending the course, highlighting the immersive nature of the program and the diverse backgrounds of participants. We discuss her key takeaways from the course, including the importance of gathering information and maximizing value in negotiations.
Here's what you're in:
- How essential is negotiation in M&A and partnering?
- What unique learning experiences does the Harvard course offers?
- How diversity in negotiation courses enhance learning?
- Why understanding hidden information is crucial in negotiations?
- How does value maximization benefit both parties in a deal?
- How negotiation skills are applicable in everyday situations?
- What is vital for effective negotiation outcomes?
- Why negotiation is for everyone, regardless of industry?
- Is Trump a good negotiator?
- How could the Harvard Negotiation Course benefit people working in clinical research?
Watch episodes here:
- Apple Podcast: Negotiation Strategies and Insights from Harvard Course
- Spotify: Negotiation Strategies and Insights from Harvard Course
Timestamps:
01:41 Introduction to Bracco and Career Background
04:40 The Harvard Negotiation Course Experience - What's in it?
12:26 Key Takeaways from the Course
18:29 The Qualities of a Good Negotiator
20:42 How Good Negotiators Do Negotiation
26:44 Negotiating Better Salaries and Promotions
30:15 Final Thoughts on Negotiation
Harvard Negotiation Course:
The "Changing the Game: Negotiation and Competitive Decision-Making" program at Harvard Business School (HBS) is a six-day intensive, in-person course aimed at improving negotiation and decision-making skills. It takes place on the HBS campus in Boston, Massachusetts, with upcoming sessions usually running every quarter. The cost of the program is $14,500.
The course is taught by experienced HBS faculty specializing in negotiation and competitive strategies. Participants engage in hands-on exercises, simulations, case studies, and faculty-led discussions to refine their negotiation techniques and decision-making abilities. The program also includes premium accommodations and access to HBS's fitness and wellness facilities to enhance the learning experience..
You can find more details on the official HBS Executive Education page.
Link to the course: https://www.exed.hbs.edu/changing-game-negotiation-competitive-decision-making
About Sophie
- Sophie He is the Head of M&A and Partnering at Bracco, the globally leading players in diagnostic pharmaceuticals.
- She has over a decade of experience in the pharmaceutical industry. She has been heavily involved in M&A and business development, which goes with her passion of negotiation.
- Prior to her roles in pharma, she gained experience in consulting and banking. She holds a PhD from MIT and NUS (National Univeristy of Singapore), has recently attended a Harvard Course, and is a CFA holder.
Connect with Sophie: https://www.linkedin.com/in/sophie-he-phd/
About Bracco:
- Bracco is an Italian multinational healthcare company renowned for its leadership in diagnostic imaging.
- The company's core focus is on diagnostic imaging, offering a comprehensive range of products for X-ray, CT, MRI, ultrasound, and nuclear medicine.
- In addition to contrast agents, Bracco provides advanced medical devices and contrast-agent injection systems.
- Key milestones in its history include the launch of Iopamidol in 1981, which positioned Bracco as a leader in non-ionic contrast agents, and the acquisition of Blue Earth Diagnostics in 2019 to expand into molecular imaging.
Website: https://www.bracco.com/
About Me
My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.
In 2023, I decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.
Connect with me: https://www.linkedin.com/in/charles-spence-clinical/
